Compile Data Set for Download or QSAR
Report error Found 96 Enz. Inhib. hit(s) with all data for entry = 1704
TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336124(US9744148, 1)
Affinity DataIC50: 39nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336128(US9744148, 2)
Affinity DataIC50: 70nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336130(US9744148, 4)
Affinity DataIC50: 80nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336129(US9744148, 3)
Affinity DataIC50: 80nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336132(US9744148, 5)
Affinity DataIC50: 90nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336133(US9744148, 6)
Affinity DataIC50: 120nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336134(US9744148, 7)
Affinity DataIC50: 130nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336135(US9744148, 8)
Affinity DataIC50: 140nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336136(US9744148, 9)
Affinity DataIC50: 150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336137(US9744148, 31 | US9744148, 10)
Affinity DataIC50: 150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336138(US9744148, 11)
Affinity DataIC50: 150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336142(US9744148, 23 | US9744148, 12)
Affinity DataIC50: 150nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336143(US9744148, 13)
Affinity DataIC50: 170nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336145(US9744148, 14)
Affinity DataIC50: 180nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336146(US9744148, 15)
Affinity DataIC50: 180nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336147(US9744148, 16)
Affinity DataIC50: 190nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336148(US9744148, 17)
Affinity DataIC50: 190nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336149(US9744148, 18)
Affinity DataIC50: 220nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336150(US9744148, 19)
Affinity DataIC50: 230nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336151(US9744148, 20)
Affinity DataIC50: 230nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336152(US9744148, 21)
Affinity DataIC50: 260nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336153(US9744148, 22)
Affinity DataIC50: 260nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336142(US9744148, 23 | US9744148, 12)
Affinity DataIC50: 270nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336155(US9744148, 24)
Affinity DataIC50: 280nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336156(US9744148, 25)
Affinity DataIC50: 310nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336157(US9744148, 26)
Affinity DataIC50: 320nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336158(US9744148, 27)
Affinity DataIC50: 330nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336159(US9744148, 28)
Affinity DataIC50: 340nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336160(US9744148, 29)
Affinity DataIC50: 350nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336161(US9744148, 30)
Affinity DataIC50: 360nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336137(US9744148, 31 | US9744148, 10)
Affinity DataIC50: 370nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336163(US9744148, 32)
Affinity DataIC50: 380nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336164(US9744148, 33)
Affinity DataIC50: 390nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336165(US9744148, 34)
Affinity DataIC50: 390nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336166(US9744148, 35)
Affinity DataIC50: 410nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336167(US9744148, 36)
Affinity DataIC50: 430nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336168(US9744148, 37)
Affinity DataIC50: 460nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336169(US9744148, 38)
Affinity DataIC50: 470nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336170(US9744148, 39)
Affinity DataIC50: 480nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336171(US9744148, 40)
Affinity DataIC50: 550nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336172(US9744148, 41)
Affinity DataIC50: 580nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336173(US9744148, 42)
Affinity DataIC50: 590nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336174(US9744148, 43)
Affinity DataIC50: 630nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336175(US9744148, 44)
Affinity DataIC50: 640nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336176(US9744148, 85 | US9744148, 45)
Affinity DataIC50: 660nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336177(US9744148, 46)
Affinity DataIC50: 690nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336178(US9744148, 47)
Affinity DataIC50: 740nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336179(US9744148, 48)
Affinity DataIC50: 760nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336180(US9744148, 49)
Affinity DataIC50: 780nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

TargetKallikrein-7(Human)
Sixera Pharma

US Patent
LigandPNGBDBM336181(US9744148, 50)
Affinity DataIC50: 790nMAssay Description:Substrate:(MeO-Suc-Arg-Pro-Tyr-pNA), acetate salt, Peptide international, lot #906841, previously named S-2586Enzyme: Active human KLK7 (SCCE) 0.62 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/5/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: